Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Renal Allograft Failure”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Post-approval studies (Phase 4)Study completedNCT01990118
What this trial is testing

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

Who this might be right for
End Stage Renal Failure
Penang Hospital, Malaysia 106
Testing effectiveness (Phase 2)Study completedNCT02134314
What this trial is testing

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Who this might be right for
End Stage Renal DiseaseKidney FailureDelayed Graft Function+1 more
Cedars-Sinai Medical Center 70
Large-scale testing (Phase 3)Study completedNCT01680861
What this trial is testing

Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium

Who this might be right for
Transplant; Failure, Kidney
Gaetano Ciancio 32
Large-scale testing (Phase 3)UnknownNCT03386539
What this trial is testing

Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score

Who this might be right for
Pediatric Heart TransplantationImmunosuppressionChronic Kidney Diseases+4 more
Boston Children's Hospital 211
Testing effectiveness (Phase 2)Looking for participantsNCT05027906
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Who this might be right for
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals 48
Not applicableUnknownNCT03487861
What this trial is testing

Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis

Who this might be right for
Kidney Allograft FibrosisKidney Transplant Failure and Rejection
Asan Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT01780454
What this trial is testing

Renal Allograft Tolerance Through Mixed Chimerism

Who this might be right for
End Stage Renal Disease
Massachusetts General Hospital 2
Not applicableStudy completedNCT00227045
What this trial is testing

CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients

Who this might be right for
End Stage Renal Disease
University of Michigan 20
Not applicableStudy completedNCT01143532
What this trial is testing

Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes

Who this might be right for
Kidney DiseaseKidney TransplantationKidney Failure, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 26
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Post-approval studies (Phase 4)Study completedNCT01860183
What this trial is testing

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Who this might be right for
Kidney TransplantationKidney Failure
Clinical Hospital Merkur 76
Not applicableEnded earlyNCT01296061
What this trial is testing

Kidney Transplant Failure

Who this might be right for
Acute Graft RejectionRenal Failure Chronic Requiring Dialysis
Ottawa Hospital Research Institute 270
Post-approval studies (Phase 4)Study completedNCT00282217
What this trial is testing

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

Who this might be right for
Kidney FailureKidney Diseases
Wyeth is now a wholly owned subsidiary of Pfizer 100
Large-scale testing (Phase 3)Study completedNCT00000935
What this trial is testing

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Who this might be right for
End-Stage Renal DiseaseKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableActive Not RecruitingNCT05112315
What this trial is testing

Clinical Impact of the IBox As an Early Intervention TooL

Who this might be right for
Kidney DiseasesKidney Disease, ChronicKidney Transplant Rejection+4 more
Predict4Health 507
Not applicableEnded earlyNCT00204230
What this trial is testing

MMF and Calcineurin Inhibitor Withdrawal in CAN

Who this might be right for
Immunosuppressive AgentsKidney Failure, ChronicKidney Transplantation
University Hospital Muenster 86
Testing effectiveness (Phase 2)Study completedNCT00801632
What this trial is testing

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

Who this might be right for
Kidney TransplantationKidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Large-scale testing (Phase 3)Study completedNCT00005010
What this trial is testing

Prevention of Kidney Transplant Rejection

Who this might be right for
End-Stage Renal DiseaseChronic Allograft Nephropathy
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00063817
What this trial is testing

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Who this might be right for
End-stage Renal DiseaseRenal TransplantationKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 5
Load More Results